13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

Page 6 of 9 – SEC Filing

 

 

CUSIP
No
.
713661502   Page
6 of 9

 

Item
1(a).
  Name
of Issuer:
Peregrine Pharmaceuticals, Inc.
     
Item
1(b).
 

Address
of Issuer’s Principal Executive Offices:
14282 Franklin Avenue,

Tustin,
California 92780

     
Item
2(a).
  Name
of Person Filing:
Tappan Street Partners LLC
    Tappan
Street Partners Fund L.P.
    Tappan
Street Partners Ideas Fund L.P.
    Prasad
Phatak
     
Item
2(b).
  Address
of Principal Business Office or, if None, Residence:
    33
Irving Place, Third Floor, New York, NY 10003
     
Item
2(c).
  Citizenship:
Tappan Street Partners, LLC is a Delaware limited liability company. Tappan Street Partners Fund, L.P. is a Delaware limited
partnership. Tappan Street Partners Ideas Fund, L.P. is a Delaware limited partnership. Mr. Phatak is a United States citizen.
     
Item
2(d).
  Title
of Class of Securities:
Common Stock ($0.001 par value)
     
Item
2(e).
  CUSIP
Number:
731661502
     
Item
3.
If
This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
   
  (a) Broker
or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
       
  (b) Bank
as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
       
  (c) Insurance
company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
       
  (d) Investment
company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
  (e) An
investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
       
  (f) An
employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
  (g) A
parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
       
  (h) A
savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) A
church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company
Act (15 U.S.C. 80a-3);
       
  (j) Group,
in accordance with §240.13d-1(b)(1)(ii)(J).

 

Follow Avid Bioservices Inc. (NASDAQ:CDMO)